期刊文献+

HucMSC-Ex alleviates inflammatory bowel disease via the lnc78583-mediated miR3202/HOXB13 pathway 被引量:1

原文传递
导出
摘要 As a group of nonspecific inflammatory diseases affecting the intestine,inflammatory bowel disease(IBD)exhibits the characteristics of chronic recurring inflammation,and was proven to be increasing in incidence(Kaplan,2015).IBD induced by genetic background,environmental changes,immune functions,microbial composition,and toxin exposures(Sasson et al.,2021)primarily includes ulcerative colitis(UC)and Crohn's disease(CD)with complicated clinical symptoms featured by abdominal pain,diarrhea,and even blood in stools(Fan et al.,2021;Huang et al.,2021).
出处 《Journal of Zhejiang University-Science B(Biomedicine & Biotechnology)》 SCIE CAS CSCD 2022年第5期423-431,共9页 浙江大学学报(英文版)B辑(生物医学与生物技术)
基金 supported by the Zhenjiang Key Research and Development Plan(Social Development)(No.SH2021066) the Clinical Medical Science and Technology Development Fund Project of Jiangsu University in 2018(No.JLY20180031) the Taicang Science and Technology Planning Project(No.TC2020JCYL17),China。
  • 相关文献

同被引文献4

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部